One-time, device-based treatment for heart failure
Heart failure patients suffer fluid overload that drives debilitating symptoms and frequent hospitalizations.
A one-time, minimally invasive device-based procedure leverages the body's fluid management system to offload trapped fluid and prevent recurrent buildup.
Cardiologists and hospitals treating heart failure patients use it.
Founder & CEO of Selera Medical, developing paradigm-shifting technology for heart failure patient management. Previous experience includes Innovation Fellow at Stanford Biodesign, CoS running internal operations at a healthtech startup, R&D engineer developing cardiovascular devices at Medtronic. Masters in biomedical engineering and engineering management from Duke.
Kevin is co-founder and CTO of Selera Medical, a medical device startup developing a minimally invasive therapy for congestive heart failure. Prior to this, he was an Innovation Fellow in the Stanford Byers Center for Biodesign. Kevin received his undergraduate bioengineering degree from Stanford and his PhD in bioengineering from the University of Pennsylvania, where he conducted research at the intersection of robotics, stroke rehabilitation, and cognitive neuroscience.




